Association between sodium–glucose cotransporter-2 inhibitors and risk of sudden cardiac death or ventricular arrhythmias: a meta-analysis of randomized controlled trials — Dimitrios Sfairopoulos (2021) | RDL Network
Association between sodium–glucose cotransporter-2 inhibitors and risk of sudden cardiac death or ventricular arrhythmias: a meta-analysis of randomized controlled trials
Article 2021 en
Authors
DS
Dimitrios Sfairopoulos
NZ
Nan Zhang
YW
Yueying Wang
Abstract
1 min read
SGLT2i therapy was not associated with an overall lower risk of SCD or VAs in patients with T2DM and/or HF and/or CKD. However, further research is needed since the number of SCD and VA events were relatively few leading to wide confidence intervals, and the point estimates suggested potential benefits.
Xinyi Gao, Nan Zhang, Lei Lü, Tianyu Gao, Oscar Hou In Chou, Wing Tak Wong, Carlin Chang, Abraham Ka Chung Wai, Professor Gregory Lip, Qingpeng Zhang, Gary Tse, Tong Liu, Jiandong Zhou
Discussion(0)
No comments yet. Be the first to comment.